Clinical Trials Logo

Clinical Trial Summary

The purpose of this clinical study is to evaluate acute effects of plant-based nutritional extracts on adult stem cells, using a randomized double-blinded placebo-controlled cross-over study design.


Clinical Trial Description

The purpose of this clinical study is to evaluate acute effects of plant-based nutritional extracts on adult stem cells, using a randomized double-blinded placebo-controlled cross-over study design. The research involves testing of acute effects of single doses of antioxidant-rich berry-based extracts, compared to a placebo. Blood samples are taken at baseline and 1 and 2 hours after consuming a single dose. The blood will be used to measure the numbers of different types of stem cells, to evaluate potential effects of stem cell mobilization and homing after consuming plant-based extracts. Adult stem cells are a type of cells that play a role in repairing and rejuvenating various tissue and organs in the body. At NIS Labs, we have shown that many types of plant-based nutritional products have small but reproducible and significant effects on stem cells, cytokines, and regenerative growth factors. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03388073
Study type Interventional
Source Natural Immune Systems Inc
Contact Gitte Jensen
Phone 5418840112
Email gitte@nislabs.com
Status Recruiting
Phase N/A
Start date January 30, 2018
Completion date February 2, 2020

See also
  Status Clinical Trial Phase
Active, not recruiting NCT01766934 - Non-interventional, Long-term Safety Data Collection of Zarzio® / Filgrastim HEXAL® in Stem Cell Donors
Recruiting NCT03014102 - Recombinant Human Thrombopoietin for Mobilization of Peripheral Blood Progenitor Cells for Autologous Transplantation Phase 1/Phase 2